Akero Therapeutics Inc (AKRO)
32.04
-0.30
(-0.91%)
USD |
NASDAQ |
Nov 04, 16:00
32.04
0.00 (0.00%)
After-Hours: 20:00
Akero Therapeutics Price to Book Value: 2.787 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 2.787 |
| November 01, 2024 | 2.813 |
| October 31, 2024 | 2.682 |
| October 30, 2024 | 2.671 |
| October 29, 2024 | 2.760 |
| October 28, 2024 | 2.585 |
| October 25, 2024 | 2.552 |
| October 24, 2024 | 2.501 |
| October 23, 2024 | 2.494 |
| October 22, 2024 | 2.574 |
| October 21, 2024 | 2.688 |
| October 18, 2024 | 2.717 |
| October 17, 2024 | 2.681 |
| October 16, 2024 | 2.701 |
| October 15, 2024 | 2.604 |
| October 14, 2024 | 2.611 |
| October 11, 2024 | 2.578 |
| October 10, 2024 | 2.530 |
| October 09, 2024 | 2.480 |
| October 08, 2024 | 2.449 |
| October 07, 2024 | 2.327 |
| October 04, 2024 | 2.457 |
| October 03, 2024 | 2.406 |
| October 02, 2024 | 2.541 |
| October 01, 2024 | 2.508 |
| Date | Value |
|---|---|
| September 30, 2024 | 2.496 |
| September 27, 2024 | 2.457 |
| September 26, 2024 | 2.552 |
| September 25, 2024 | 2.436 |
| September 24, 2024 | 2.440 |
| September 23, 2024 | 2.468 |
| September 20, 2024 | 2.443 |
| September 19, 2024 | 2.436 |
| September 18, 2024 | 2.346 |
| September 17, 2024 | 2.318 |
| September 16, 2024 | 2.329 |
| September 13, 2024 | 2.378 |
| September 12, 2024 | 2.236 |
| September 11, 2024 | 2.229 |
| September 10, 2024 | 2.239 |
| September 09, 2024 | 2.288 |
| September 06, 2024 | 2.298 |
| September 05, 2024 | 2.292 |
| September 04, 2024 | 2.288 |
| September 03, 2024 | 2.261 |
| August 30, 2024 | 2.366 |
| August 29, 2024 | 2.339 |
| August 28, 2024 | 2.317 |
| August 27, 2024 | 2.290 |
| August 26, 2024 | 2.378 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.087
Minimum
Oct 27 2023
12.74
Maximum
Jul 27 2020
4.354
Average
3.856
Median
Price to Book Value Benchmarks
| Amicus Therapeutics Inc | 25.38 |
| Zoetis Inc | 15.98 |
| Annovis Bio Inc | -- |
| NovaBay Pharmaceuticals Inc | -- |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| Price | 32.04 |
| Earnings Yield | -10.74% |
| Market Cap | 2.224B |